Treatment carryover impacts on effectiveness of intraocular pressure lowering agents, estimated by a discrete event simulation model.
Umuhire, D; Denis, Philippe; Le Pen, Claude; Berdeaux, Gilles (2008), Treatment carryover impacts on effectiveness of intraocular pressure lowering agents, estimated by a discrete event simulation model., European Journal of Ophthalmology, 18, 1, p. 44-51
TypeArticle accepté pour publication ou publié
Journal nameEuropean Journal of Ophthalmology
MetadataShow full item record
Abstract (EN)PURPOSE: To compare the effectiveness of two treatment sequences, latanoprost-latanoprost timolol fixed combination (L-LT) versus travoprost-travoprost timolol fixed combination (T-TT), in the treatment of open-angle glaucoma (OAG) or ocular hypertension (OHT). METHODS: A discrete event simulation (DES) model was constructed. Patients with either OAG or OHT were treated first-line with a prostaglandin, either latanoprost or travoprost. In case of treatment failure, patients were switched to the specific prostaglandin-timolol sequence LT or TT. Failure was defined as intraocular pressure higher than or equal to 18 mmHg at two visits. Time to failure was estimated from two randomized clinical trials. Log-rank tests were computed. Linear functions after log-log transformation were used to model time to failure. The time horizon of the model was 60 months. Outcomes included treatment failure and disease progression. Sensitivity analyses were performed. RESULTS: Latanoprost treatment resulted in more treatment failures than travoprost (p<0.01), and LT more than TT (p<0.01). At 60 months, the probability of starting a third treatment line was 39.2% with L-LT versus 29.9% with T-TT. On average, L-LT patients developed 0.55 new visual field defects versus 0.48 for T-TT patients. The probability of no disease progression at 60 months was 61.4% with L-LT and 65.5% with T-TT. CONCLUSIONS: Based on randomized clinical trial results and using a DES model, the T-TT sequence was more effective at avoiding starting a third line treatment than the L-LT sequence. T-TT treated patients developed less glaucoma progression.
Subjects / KeywordsTreatment; DES model; discrete event simulation
Showing items related by title and author.
Cost-effectiveness of rabies post-exposure prophylaxis in the context of very low rabies risk: A decision-tree model based on the experience of France Ribadeau Dumas, Florence; N'Diaye, Dieynaba S.; Paireau, Juliette; Gautret, Philippe; Bourhy, Hervé; Le Pen, Claude; Yazdanpanah, Yazdan (2015) Article accepté pour publication ou publié
Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden Bergström, Anders; Maurel, Frédérique; Le Pen, Claude; Lamure, Emilie; Kent, Michael; Bardoulat, Isabelle; Berdeaux, Gilles (2009) Article accepté pour publication ou publié
Efficiency of Glaucoma Drug Regulation in 5 European Countries: A 1995-2006 Longitudinal Prescription Analysis Berdeaux, Gilles; Le Pen, Claude; De Natale, Renato (2011-04) Article accepté pour publication ou publié
Le Pen, Claude; Lévy, Emile; Bonte, J. (1994) Article accepté pour publication ou publié
Effectiveness of a Lumbar Belt in Subacute Low Back Pain: An Open, Multicentric, and Randomized Clinical Study Lerouvreur, Claire; Maurel, Frederique; Le Pen, Claude; Hamonet, Claude; Queneau, Patrice; Calmels, Paul; Thoumie, Philippe (2009-02) Article accepté pour publication ou publié